by Vita | سبتمبر 2, 2016 | Articles
Zika virus (ZIKV) disease had been described as a mild, self-limiting illness associated with fever, rash, joint pain, and conjunctivitis. However, during the outbreak in French Polynesia, 42 patients with ZIKV disease were found to have the Guillain–Barré syndrome,...
by Vita | أغسطس 8, 2016 | Articles
Abstract Vitamin C is a potent antioxidant drug that can be used topically in dermatology to treat and prevent changes associated with photoageing. It can also be used for the treatment of hyperpigmentation. Because it is unstable and difficult to deliver into the...
by Vita | يوليو 14, 2016 | Articles
By Randi Hernandez Peptides and proteins generally have low bioavailability when taken by mouth, and this hurdle has generally prevented the oral delivery of many biologic drugs in the past. However, plant cell walls may be ideal transporters to move protein-based...
by Vita | يوليو 8, 2016 | Articles
More than one-third of U.S. patients with the abnormal heartbeat atrial fibrillation who need a blood thinner to prevent strokes aren’t getting one, researchers say. About 40 percent of “a-fib” patients deemed at moderate to severe risk of stroke...
by Vita | يونيو 6, 2016 | Articles
In July 2015, the FDA approved alirocumab (Praluent), the first cholesterol-lowering treatment in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. The following month, the FDA approved the second PCSK9 inhibitor,...
by Vita | يونيو 2, 2016 | Articles
Ridgefield, Conn., and Indianapolis, May 31, 2016 – The U.S. Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes (T2D) in adults. Jentadueto XR, which is...
